Syon Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Syon Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73M	Buy	23,562 +9,530	+68%	+$1.29M	0.16%	94
2026 Q1	$1.79M	Sell	14,032 -3,064	-18%	-$383K	0.09%	164
2025 Q4	$2.08M	Sell	17,096 -1,512	-8%	-$173K	0.1%	147
2025 Q3	$1.86M	Buy	18,608 +1,604	+9%	+$144K	0.1%	140
2025 Q2	$1.41M	Sell	17,004 -219	-1%	-$17.5K	0.09%	152
2025 Q1	$1.4M	Sell	17,223 -13,622	-44%	-$1.22M	0.11%	135
2024 Q4	$2.78M	Buy	+30,845	New	+$2.99M	0.25%	67

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Syon Capital's XBI Position: Q2 2026 in Review

Syon Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 68% in Q2 2026, buying an estimated $1.29M and bringing the position to 23,562 shares worth $3.73M. The position accounts for 0.16% of the portfolio, ranked #94.

Syon Capital first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Syon Capital held 23,562 shares of State Street SPDR S&P Biotech ETF worth $3.73M as of Q2 2026.
Syon Capital bought 9,530 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.29M.
State Street SPDR S&P Biotech ETF made up 0.16% of Syon Capital's portfolio in Q2 2026, its #94 holding.
Syon Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.